SCHEMBL14093003

SCHEMBL14093003

CC(C)(C)c1ccc2cn[nH]c2c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS1 P29475 6/20 0.46
▸ MAPT P10636 3/20 0.43
▸ TRPA1 O75762 2/20 0.38
▸ DYRK1A Q13627 2/20 0.38
▸ HTT P42858 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ SLC2A1 P11166 1/20 0.34
▸ FGFR1 P11362 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ PLK4 O00444 1/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ DAPK3 O43293 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ CSF1R P07333 1/20 0.33
▸ RET P07949 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ LTK P29376 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22793062 0.80 MAPT (0.44) NOS1MAPTTRPA1DYRK1AHTT
SCHEMBL23083828 0.76 MAPT (0.61) NOS1MAPTTRPA1DYRK1AHTT
SCHEMBL17030770 0.75 NOS1 (0.50) NOS1MAPTTRPA1DYRK1AHTT
SCHEMBL6983718 0.74 NOS1 (0.53) NOS1MAPTTRPA1ALDH1A1FGFR1
SCHEMBL31104474 0.72 NOS1 (0.55) NOS1MAPTDYRK1AHTTALDH1A1
SCHEMBL1072434 0.72 MAPT (0.52) NOS1MAPTDYRK1AHTTALDH1A1
SCHEMBL2269592 0.72 NOS1 (0.50) NOS1MAPTDYRK1AHTTALDH1A1
SCHEMBL25395813 0.72 NOS1 (0.50) NOS1MAPTDYRK1AHTTALDH1A1
SCHEMBL19785592 0.72 NOS1 (0.55) NOS1MAPTDYRK1AHTTALDH1A1
SCHEMBL22349090 0.71 NOS1 (0.42) NOS1TRPA1KMT2ACHEK1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7417053-B2 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof TEIJIN PHARMA LIMITED (JP) 2008-08-26 — — US disclosed
US-20070072898-A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof TEIJIN PHARMA LIMITED 2007-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072898-A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof MAPKAPK2, MAP4K2, MAPKAPK5 NOS1 2925/4885MAPT 1996/4885TRPA1 1435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback